Skip to Content

Kidney Disease, Injury Linked to Higher Mortality With COVID-19

TUESDAY, Oct. 20, 2020 -- Renal impairment in patients admitted to intensive care with COVID-19 is common and is associated with high mortality, according to a study published online Oct. 16 in Anaesthesia.

Marisa Gasparini, M.B.B.S., from the Imperial College Healthcare NHS Trust in London, and colleagues examined the association between acute and chronic kidney disease and clinical outcomes in 372 patients with COVID-19 admitted to four regional intensive care units (ICUs) between March 10 and July 31, 2020.

The researchers found that 58 percent of patients presented with COVID-19 and renal impairment (45 percent developed acute kidney injury [AKI] during their ICU stay and 13 percent had preexisting chronic kidney disease [CKD]). Compared with patients with preserved renal function, patients with AKI and/or CKD had greater in-hospital mortality (21 versus 50 percent; relative risk, 2.4). Mortality was greatest in patients with renal transplants (six of seven patients). Mortality rates increased with worsening renal injury (Kidney Disease: Improving Global Outcomes classification stage 0: mortality, 21 percent; stages 1 to 3: mortality, 49 percent; relative risk 2.3). Compared with nonsurvivors, survivors were less likely to require renal replacement therapy (46 versus 24 percent; relative risk, 1.9). Of survivors who required renal replacement therapy acutely in intensive care, one-fifth continued to require renal support following discharge.

"Our findings have important implications for future pandemic planning in this patient cohort," the authors write.

Abstract/Full Text

© 2020 HealthDay. All rights reserved.

Posted: October 2020

Read this next

AHA Meeting Addresses Latest Research, COVID-19, Health Care Disparities

MONDAY, Nov. 23, 2020 -- Fresh takes on the efficacy of fish oil and vitamin D, new treatments for heart failure patients, the cardiovascular effects of COVID-19, and structural...

FDA Authorizes Use of Monoclonal Antibody Treatment for COVID-19

MONDAY, Nov. 23, 2020 -- A combination of two monoclonal antibodies was granted emergency use authorization (EUA) for the treatment of mild-to-moderate COVID-19, the U.S. Food and...

AHA: Blacks, Hispanics Make Up 53 Percent of COVID-19 Deaths

MONDAY, Nov. 23, 2020 -- Due to disproportionate representation, Black and Hispanic patients bear much of the burden of mortality and morbidity related to COVID-19, according to a...